Routine cytogenetics with automatic addition of the NeoTYPE™ AML Prognostic Profile when cytogenetics results show intermediate risk including normal cytogenetics, +6, +8, -Y, or del(12p).
The AML Reflex Panel combines cytogenetics and molecular testing to identify AML patients with intermediate-risk cytogenetic abnormalities that can benefit from molecular profiling. Use of the NeoTYPE AML Prognostic Profile in these patients can improve risk stratification by confirming intermediate risk or reclassifying patients to favorable or unfavorable risk categories.
- Peripheral blood: 2-5 mL in sodium heparin tube and 2x5 mL in EDTA tube.
- Bone marrow: 1-2 mL in sodium heparin tube and 2 mL in EDTA tube.
Storage and Transportation
Use cold pack for transport, making sure cold pack is not in direct contact with specimen.
88235 or 88237, and 88291. With reflex to molecular testing, add molecular codes corresponding to the NeoTYPE AML Prognostic Profile.